Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524428 · ClinicalTrials.gov registry record · NA
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
A NA study of Colorectal Cancer, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 4
- Study locations
NCT05524428: Recruiting NA study of Colorectal Cancer, sponsored by Massachusetts General Hospital.
NCT05524428 is a NA study of Colorectal Cancer that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 2 participants, below the 1,545-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05524428, a NA study of Colorectal Cancer, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.
Primary Outcome
The investigators will measure the acceptability of the implementation strategies determined in Aim 2. This will be measured through a post-implementation survey given to the CHC staff members who participate in systems-level implementation at the two CHC pilot test sites in Aim 3.
Conditions Studied
Interventions
- BEHAVIORAL Implementation Science Strategy
Study Locations (4)
Massachusetts
- Codman Square Health Center - Boston
- Brockton Neighborhood Health Center - Brockton
- East Boston Neighborhood Health Center - East Boston
- Duffy Health Center - Hyannis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-03-24 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05524428 shows while recruiting
NCT05524428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,545-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Implementation Science Strategy is the first listed.
NCT05524428 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05524428 about?
NCT05524428 is a clinical study titled "Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study". The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.
What is the current status of trial NCT05524428?
This trial is currently recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2023-03-24. Estimated completion is 2026-12.
What conditions does trial NCT05524428 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT05524428?
The interventions under investigation include: Implementation Science Strategy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05524428?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05524428 being conducted?
This trial has 4 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05524428's enrollment target sits among peer trials
2 378th of 381 higher than 2 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI